HIV protease inhibitors with picomolar potency against PI-Resistant HIV-1 by extension of the P3 substituent

HIV protease inhibitors with picomolar potency against PI-Resistant HIV-1 by extension of the P3 substituent HIV-1 protease inhibitors with picomolar potency against PI-resistant HIV-1 by modification of the P1′ substituent The design, synthesis and evaluation of novel HIV-1 protease inhibitors with high potency against PI-resistant viral strains Novel HIV-1 protease inhibitors active against multiple PI-Resistant viral strains: coadministration with indinavir Synthesis and activity of novel HIV protease inhibitors with improved potency against multiple PI-resistant viral strains Synthesis of novel HIV protease inhibitors (PI) with activity against PI-resistant virus P1′ oxadiazole protease inhibitors with excellent activity against native and protease inhibitor-resistant HIV-1 Orally bioavailable highly potent HIV protease inhibitors against PI-resistant virus Nonsymmetric P2/P2‘ Cyclic Urea HIV Protease Inhibitors. Structure−Activity Relationship, Bioavailability, and Resistance Profile of Monoindazole-Substituted P2 Analogues Novel inhibitors of HIV protease